Harmony Biosciences Holdings (HRMY)
US Market

Harmony Biosciences Holdings (HRMY) Stock Price & Analysis


HRMY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$29.81 - $62.09
Previous Close$35.56
Average Volume (3M)902.46K
Market Cap
Enterprise Value$1.98B
Total Cash (Recent Filing)$343.88M
Total Debt (Recent Filing)$191.56M
Price to Earnings (P/E)11.5
Aug 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.09
Shares Outstanding59,954,618
10 Day Avg. Volume395,321
30 Day Avg. Volume902,455
Standard Deviation0.14
Financial Highlights & Ratios
Price to Book (P/B)7.49
Price to Sales (P/S)18.11
Price to Cash Flow (P/CF)12.70
P/FCF Ratio11.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.77
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda19.13
Price Target Upside72.75% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Harmony Biosciences Holdings’s price range in the past 12 months?
Harmony Biosciences Holdings lowest stock price was $29.81 and its highest was $62.09 in the past 12 months.
    What is Harmony Biosciences Holdings’s market cap?
    Currently, no data Available
    When is Harmony Biosciences Holdings’s upcoming earnings report date?
    Harmony Biosciences Holdings’s upcoming earnings report date is Aug 08, 2023 which is in 72 days.
      How were Harmony Biosciences Holdings’s earnings last quarter?
      Harmony Biosciences Holdings released its earnings results on May 02, 2023. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.471 by $0.009.
        Is Harmony Biosciences Holdings overvalued?
        According to Wall Street analysts Harmony Biosciences Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Harmony Biosciences Holdings pay dividends?
          Harmony Biosciences Holdings does not currently pay dividends.
          What is Harmony Biosciences Holdings’s EPS estimate?
          Harmony Biosciences Holdings’s EPS estimate is $0.63.
            How many shares outstanding does Harmony Biosciences Holdings have?
            Harmony Biosciences Holdings has 59,954,617 shares outstanding.
              What happened to Harmony Biosciences Holdings’s price movement after its last earnings report?
              Harmony Biosciences Holdings reported an EPS of $0.48 in its last earnings report, beating expectations of $0.471. Following the earnings report the stock price went up 2.411%.
                Which hedge fund is a major shareholder of Harmony Biosciences Holdings?
                Among the largest hedge funds holding Harmony Biosciences Holdings’s share is Neumeier Poma Investment Counsel LLC. It holds Harmony Biosciences Holdings’s shares valued at 22M.


                  Harmony Biosciences Holdings Stock Smart Score

                  The Harmony Biosciences Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Harmony Biosciences Holdings

                  Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs.


                  Top 5 ETFs holding HRMY

                  Market Value
                  Smart Score
                  Vanguard Health Care ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  First Trust US Equity Opportunities ETF
                  Fidelity Nasdaq Composite Index ETF
                  Fidelity MSCI Health Care Index ETF
                  Up to five ETFs with an Outperform Smart Score that hold HRMY. The ETFs are listed according to market value of HRMY within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Elanco Animal Health
                  Intra-Cellular Therapies

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis